Overview

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
Phase:
Phase 2
Details
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Treatments:
Ophthalmic Solutions
Criteria
Inclusion Criteria:

- Corneal and conjunctival damage

- Insufficiency of lacrimal secretion

- Ocular symptom

Exclusion Criteria:

- Severe ophthalmic disorder

- Punctual plugs or surgery for occlusion of the lacrimal puncta